Galit Zuckerman Stark, CEO and cofounder of Medasense. Medasense is NOL technology, enables clinician to personalize pain management, optimize treatment and avoid overmedication. All this in it with a noninvasive sensor platform and AI technology.
01:14 What brought you to the medical field and to becoming the CEO of a breakthrough product in what is actually a very difficult market to operate in?
03:18 How did you get to pain as a field of interest?
05:05 Why is there a need for an objective measurement of pain?
09:05 Can you go back to 10-11 years ago and share what you were thinking your product process was going to be? And then go to, where you are now and what your product actually is?
13:40 What do you think are the main things that have changed in the “Pain industry” and allowed you to sell products and raise significant amounts of capital from investors?
16:46 Can you explain a little bit about how Medasense’s technology works?
20:03 How is Medasense’s pain score personalized?
20:59 Are you only addressing the pain component of surgery or are you helping the anesthesiologist manage the types of medications administered during surgery?
22:54 How and why did you make the decision to work with a large multinational company such as Medtronic for distribution?
26:08 it's quite unusual for an Israeli company to start with Europe. Why did you decide to begin your sales in Europe?
28:50 How do you make sure you don’t lose touch with the market when you sell through distributors?
34:10 Who helped you during the transition from a product company to a commercialization
36:59 What's next for Medasense?
41:05 How does your product work with patients who can communicate? How can you reconcile the gap between your measurement and what the patient is saying?
43:20 Do you think you have different challenges because you're a female CEO in this space? And if so, you know, do you have any tips for other female CEOs?
Galit Zuckerman Stark, CEO and cofounder of Medasense. Medasense is NOL technology, enables clinician to personalize pain management, optimize treatment and avoid overmedication. All this in it with a noninvasive sensor platform and AI technology.
01:14 What brought you to the medical field and to becoming the CEO of a breakthrough product in what is actually a very difficult market to operate in?
03:18 How did you get to pain as a field of interest?
05:05 Why is there a need for an objective measurement of pain?
09:05 Can you go back to 10-11 years ago and share what you were thinking your product process was going to be? And then go to, where you are now and what your product actually is?
13:40 What do you think are the main things that have changed in the “Pain industry” and allowed you to sell products and raise significant amounts of capital from investors?
16:46 Can you explain a little bit about how Medasense’s technology works?
20:03 How is Medasense’s pain score personalized?
20:59 Are you only addressing the pain component of surgery or are you helping the anesthesiologist manage the types of medications administered during surgery?
22:54 How and why did you make the decision to work with a large multinational company such as Medtronic for distribution?
26:08 it's quite unusual for an Israeli company to start with Europe. Why did you decide to begin your sales in Europe?
28:50 How do you make sure you don’t lose touch with the market when you sell through distributors?
34:10 Who helped you during the transition from a product company to a commercialization
36:59 What's next for Medasense?
41:05 How does your product work with patients who can communicate? How can you reconcile the gap between your measurement and what the patient is saying?
43:20 Do you think you have different challenges because you're a female CEO in this space? And if so, you know, do you have any tips for other female CEOs?